Connection

Bryan Love to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Bryan Love has written about Cost-Benefit Analysis.
Bryan Love
Connection Strength
0.617
Cost-Benefit Analysis
  1. Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses. J Manag Care Spec Pharm. 2020 Jul; 26(7):879-886.
    View in: PubMed
    Score: 0.617
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.